Modern possibilities of minimally invasive methods of diagnosis and treatment in China
https://doi.org/10.17650/1994-4098-2016-12-1-19-25
Abstract
Breast cancer is now the most common cancer that threatens the health of women in China. The annual number of new cases of breast cancer and the number of deaths in China is 12.2 and 9.6 % respectively of the total amount in the world. Following the scientific and technological progress in the development direction of surgery for breast cancer has been the development in the field of endoscopic surgery, this treatment method with little section provides a good therapeutic result. Along with the aesthetic appearance of cure is achieved at the site of surgery and minimizing the trauma. In China use system “Mammotome” and dustoscopic for preoperative biopsy; and through mastoscopic do breast-conserving surgery, operations mastectomy in breast cancer and reconstruction, sentinel lymph node biopsy, and axillary lymph node dissection; ablation. In China now fully implemented the treatment of breast cancer minimally invasive techniques which is the general trend of the development of surgery in the country.
About the Authors
Kuo Chen
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia; Build. 2, 8 Trubetskaya St., Moscow, 119991, Russia
N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia; 23 Kashirskoe Shosse, Moscow, 115478, Russia
Russian Federation
Russian Federation
Le Zhang
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia; Build. 2, 8 Trubetskaya St., Moscow, 119991, Russia
N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia; 23 Kashirskoe Shosse, Moscow, 115478, Russia
Russian Federation
Russian Federation
References
1. Zheng Y., Wu C.X., Wu F. Status and trends of breast cancer mortality in Chinese females. Zhonghua Yu Fang Yi Xue Za Zhi 2011;45(2):150–4.
2. Hung W.K., Ying M., Chan C.M. et al. Minimally invasive technology in the management of breast disease. Breast Cancer 2009;16(1):23–9.
3. Silverstein M.J., Recht A., Lagios M.D. et al. Special report: Consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment. J Am Coll Surg 2009;209(4):504–20.
4. Sonoo H. Current status and future prospect s f or breast cancer therapy. Nihon Rinsho 2007;65 Suppl 6:391–5.
5. Deng Q., Cui M. Development of minimally invasive therapy for breast cancer. Med Recapitulate 2009;15(23):3554–7.
6. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists’ Collaborative Group. New Engl J Med 1995;333(22):1444–55.
7. Kompatscher P. Endoscopic capsulotomy of capsular contracture after breast augmentation: a very challenging therapeutic approach. Plast Reconstr Surg 1992;90(6):1125–6.
8. Friedlander L.D., Sundin J., Bakshandeh N. Endoscopy mast ectomy and breast reconstruction: endoscopic breast surgery. Aesthetic Plast Surg 1995;19(1):27–9.
9. Ishiguro K., Nakamum H., Tanaka Y. et al. Endoscope-assisted breast-conserving surgery. Jpn J Breast Cancer 1999;14(2):287–90.
10. Tamaki Y., Nakano Y., Sekimoto M. et al. Transaxillary endoscopic partial mast ectomy for comparativel y early-stage breast cancer. An early experience. Surg Laparosc Endosc 1998;8(4):308–12.
11. Mahmoud H.H., Leverger G., Patte C. et al. Advances in themanagement of malignancy-associated hyperuricaemia. Br J Cancer 1998;77(Suppl 4):18–20.
12. Cahill R.A., Salman R., Diqmond L. et al. Minimally invasive breast surgery. J Am Coll Surg 2005;201(1):150–2.
13. Parikh J., Tickman R. Image-guided tissue smapling: where radiology meets pathology. Breast 2005;11(6):403–9.
14. Ikeda T. Present status and future perspective of surgical therapy for breast neoplasms. Nihon Rinsho 2007;65 Suppl 6: 434–8.
15. Sakorafas G.H., Farley D.R., Peros G. Recent advances and current controversies in the management of DCIS of the breast. Cancer Treat Rev 2008;34(6):483–97.
16. Iwase T., Takahashi K., Gomi N. et al. Present state of and problems with core needle biopsy for non-palpable breast lesions. Breast Cancer 2006;13(1):32–7.
17. Law T.T., Kwong A. Surgical margins in breast conservation therapy: how much should we excise? South Med J 2009;102(12):1234–7.
18. Kramer S., Darsow M., Kummel S. et al. Breast-conserving treatment of breast cancer – oncological and reconstructive aspects. Gynakol Geburtshilfliche Rundsch 2008;48(2):56–62.
19. Singletary S.E., Dowlatshahi K., Dooley W. et al. Minimally invasive operation for breast cancer. Curr Probl Surg 2004;41(4): 394–447.
20. Doridot V., Nos C., Aucouturier J.S. et al. Breast-conserving therapy of breast cancer. Cancer Radiother 2004;8(1):21–8.
21. Newman L.A., Washington T.A. New trends in breast conservation therapy. Surg Clin North Am 2003;83(4):841–83.
22. Graves T.A., Bland K.I. Surgery for early and minimally invasive breast cancer. Curr Opin Oncol 1996;8(6):468–77.
23. Smith T. The role and extent of surgery in early invasive breast cancer. Semin Oncol 1996;23(1 Suppl 2):12–8.
24. Cobum M.C., Bland K.I. Surgery for early and minimally invasive breast cancer. Curr Opin Oncol 1995;7(6):506–10.
25. Deo S.V., Varma M.C., Shukla N.K. Management of patients with breast cancer: are we ready in India for sentinel lymph node biopsy? Natl Med J India 2008;21(1): 27–30.
26. Ballester Sapiña J.B., González Noguera P.J., Casterá March J.A. et al. Radioguided breast surgery. Evolution of the use of minimalinvasive technologies and current situation. Cir Esp 2008;83(4):167–72.
27. Somasundaram S.K., Chicken D.W., Keshtgar M.R. Detection of the sentinel lymph node in breast cancer. Br Med Bull 2007;84(1):117–31.
28. Ferrari A., Rovera F., Dionigi P. et al. Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer. Expert Rev Anticancer Ther 2006;6(10):1503–15.
29. Kuhl C., Kuhn W., Braun M., Schild H. Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back? Breast 2007;16 Suppl 2:S34–44.
30. Sakorafas G.H., Peros G. Sentinel lymph node biopsy in breast cancer: what a physician should know, a decade after its introduction in clinical practice. Eur J Cancer Care (Engl) 2007;16(4):318–21.
31. Motomura K., Egawa C., Komoike Y. et al. Sentinel node biopsy breast cancer: technical aspects and controversies. Breast Cancer 2007;14(1):25–30.
32. Chen S.L., Iddings D.M., Scheri R.P., Bilchik A.J. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin 2006;56(5): 292–309.
33. Hussein O., El-Nahhas W., El-Saed A., Denewer A. Video-assisted axillary surgery for cancer: non-randomized comparison with conventional techniques. Breast 2007;16(5):513–9.
34. Kühn T., Santjohanser C., Koretz K. et al. Axilloscopy and endoscopic sentinel node detection in breast cancer patients. Surg Endosc 2000;14(6):573–7.
35. Chagpar A.B., McMasters K.M. Treatment of sentinel node positive breast cancer. Expert Rev Anticancer Ther 2006;6(8):1233–9.
36. Keshtgar M.R., Chicken D.W., Tobias J.S. New approaches in breast cancer management: sentinel node biopsy and intraoperative radiotherapy. Int J Fertil Womens Med 2005;50(5 Pt 1):218–26.
37. Morrow M. Sentinel lymph node biopsy: benefits and limitations. Zentralbl Gynakol 2003;125(9):335–7.
38. Thompson J.F., Uren R.F., Scolyer R.A., Stretch J.R. Selective sentinel lymphadenectomy: progress to date and prospects for the future. Cancer Treat Res 2005;127:269–87.
39. Tuttle T.M. Sentinel lymph node biopsy. Preferred method of axillary staging for breast cancer. Minerva Ginecol 2005;57(3):293–303.
40. Moran C.J., Kell M.R., Kerin M.J. The role of sentinel lymph node biopsy in ductal carcinom a in situ. Eur J Surg Oncol 2005;31(10):1105–11.
41. Hamazoe R., Maeta M., Murakami A. et al. Heating efficiency of radiofrequency capacitive hyperthermia for treatment of deep-seated tumors in the peritoneal cavity. J Surg Oncol 1991;48(3):176–9.
42. Jolesz F.A., Hynynen K., McDannold N., Tempany C. MR imaging-controlled focused ultrasound ablation: a noninvasive imageguided surgery. Magn Reson Imaging Clin N Am 2005;13(3):545–60.
43. Gasparini G., Longo R., Torino F., Morabito A. Therapy of breast cancer with molecular targeting agents. Ann Oncol 2005; 16 Suppl 4:iv28–36.
44. Whitworth P.W., Rewcastle J.C. Cryoablation and cryolocalization in the management of breast disease. J Surg Oncol 2005;90(1):1–9.
45. Hoffmann N.E., Bischof J.C. The cryobiology of cryosurgical injury. Urology 2002;60(2 Suppl 1):40–9.
46. Rand R.W., Rand R.P., Eggerding F. et al. Cryolumpectomy for carcinoma of the breast. Surg Gynecol Obstet 1987;165(5):392–6.
47. Mumtaz H., Hall-Craggs M.A., Wotherspoon A. et al. Laser therapy for breast cancer: MR imaging and histopathologic correlation. Radiology 1996;200(3):651–8.
48. Harms S.E. MR-guided minimally invasive procedures. Magn Reson Imaging Clin N Am 2001;92(9):381–92.
Review
For citations:
Chen K., Zhang L. Modern possibilities of minimally invasive methods of diagnosis and treatment in China. Tumors of female reproductive system. 2016;12(1):19-25. (In Russ.) https://doi.org/10.17650/1994-4098-2016-12-1-19-25
Views:
770
Email this article 